142 related articles for article (PubMed ID: 9836474)
1. Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators. Cancer Research Campaign/British Prostate Group.
Dunsmuir WD; Edwards SM; Lakhani SR; Young M; Corbishley C; Kirby RS; Dearnaley DP; Dowe A; Ardern-Jones A; Kelly J; Eeles RA
Br J Cancer; 1998 Dec; 78(11):1430-3. PubMed ID: 9836474
[TBL] [Abstract][Full Text] [Related]
2. Low frequency of allelic imbalance at the prostate cancer susceptibility loci HPC1 and 1p36 in Swedish men with hereditary prostate cancer.
Ahman AK; Jonsson BA; Damber JE; Bergh A; Emanuelsson M; Grönberg H
Genes Chromosomes Cancer; 2000 Dec; 29(4):292-6. PubMed ID: 11066072
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study.
Cooney KA; McCarthy JD; Lange E; Huang L; Miesfeldt S; Montie JE; Oesterling JE; Sandler HM; Lange K
J Natl Cancer Inst; 1997 Jul; 89(13):955-9. PubMed ID: 9214675
[TBL] [Abstract][Full Text] [Related]
4. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer.
Bergthorsson JT; Johannesdottir G; Arason A; Benediktsdottir KR; Agnarsson BA; Bailey-Wilson JE; Gillanders E; Smith J; Trent J; Barkardottir RB
Hum Genet; 2000 Oct; 107(4):372-5. PubMed ID: 11129338
[TBL] [Abstract][Full Text] [Related]
5. Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.
Eeles RA; Durocher F; Edwards S; Teare D; Badzioch M; Hamoudi R; Gill S; Biggs P; Dearnaley D; Ardern-Jones A; Dowe A; Shearer R; McLellan DL; Norman RL; Ghadirian P; Aprikian A; Ford D; Amos C; King TM; Labrie F; Simard J; Narod SA; Easton D; Foulkes WD
Am J Hum Genet; 1998 Mar; 62(3):653-8. PubMed ID: 9497242
[TBL] [Abstract][Full Text] [Related]
6. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
[TBL] [Abstract][Full Text] [Related]
7. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.
Xu J
Am J Hum Genet; 2000 Mar; 66(3):945-57. PubMed ID: 10712209
[TBL] [Abstract][Full Text] [Related]
8. Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25.
McIndoe RA; Stanford JL; Gibbs M; Jarvik GP; Brandzel S; Neal CL; Li S; Gammack JT; Gay AA; Goode EL; Hood L; Ostrander EA
Am J Hum Genet; 1997 Aug; 61(2):347-53. PubMed ID: 9311739
[TBL] [Abstract][Full Text] [Related]
9. In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer.
Grönberg H; Smith J; Emanuelsson M; Jonsson BA; Bergh A; Carpten J; Isaacs W; Xu J; Meyers D; Trent J; Damber JE
Am J Hum Genet; 1999 Jul; 65(1):134-40. PubMed ID: 10364525
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
11. Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.
Berry R; Schaid DJ; Smith JR; French AJ; Schroeder JJ; McDonnell SK; Peterson BJ; Wang ZY; Carpten JD; Roberts SG; Tester DJ; Blute ML; Trent JM; Thibodeau SN
Am J Hum Genet; 2000 Feb; 66(2):539-46. PubMed ID: 10677314
[TBL] [Abstract][Full Text] [Related]
12. Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours.
Latil A; Cussenot O; Fournier G; Lidereau R
Int J Cancer; 1997 Jun; 71(6):1118. PubMed ID: 9185721
[No Abstract] [Full Text] [Related]
13. Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer. CRC/BPG UK Familial Prostate Cancer Study Collaborators.
Edwards SM; Dunsmuir WD; Gillett CE; Lakhani SR; Corbishley C; Young M; Kirby RS; Dearnaley DP; Dowe A; Ardern-Jones A; Kelly J; Spurr N; Barnes DM; Eeles RA
Int J Cancer; 1998 Sep; 78(1):1-7. PubMed ID: 9724085
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees.
Neuhausen SL; Farnham JM; Kort E; Tavtigian SV; Skolnick MH; Cannon-Albright LA
Hum Mol Genet; 1999 Dec; 8(13):2437-42. PubMed ID: 10556291
[TBL] [Abstract][Full Text] [Related]
15. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus.
Grönberg H; Isaacs SD; Smith JR; Carpten JD; Bova GS; Freije D; Xu J; Meyers DA; Collins FS; Trent JM; Walsh PC; Isaacs WB
JAMA; 1997 Oct; 278(15):1251-5. PubMed ID: 9333266
[TBL] [Abstract][Full Text] [Related]
17. Linkage analysis of 150 high-risk prostate cancer families at 1q24-25.
Goode EL; Stanford JL; Chakrabarti L; Gibbs M; Kolb S; McIndoe RA; Buckley VA; Schuster EF; Neal CL; Miller EL; Brandzel S; Hood L; Ostrander EA; Jarvik GP
Genet Epidemiol; 2000 Mar; 18(3):251-75. PubMed ID: 10723109
[TBL] [Abstract][Full Text] [Related]
18. Linkage of prostate cancer susceptibility loci to chromosome 1.
Xu J; Zheng SL; Chang B; Smith JR; Carpten JD; Stine OC; Isaacs SD; Wiley KE; Henning L; Ewing C; Bujnovszky P; Bleeker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB
Hum Genet; 2001 Apr; 108(4):335-45. PubMed ID: 11379880
[TBL] [Abstract][Full Text] [Related]
19. Allelic imbalance in hereditary and sporadic prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Prostate; 2003 Jan; 54(1):50-7. PubMed ID: 12481255
[TBL] [Abstract][Full Text] [Related]
20. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
